• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

垂体腺瘤侵犯海绵窦内侧壁:术中评估及海绵窦内侧壁切除术治疗生长激素腺瘤的临床疗效

Invasion of the Cavernous Sinus Medial Wall by Pituitary Adenomas: Intraoperative Evaluation and the Clinical Efficacy of the Cavernous Sinus Medial Wall Resection in the Treatment of Somatotroph Adenomas.

作者信息

Liang Xiao, Fan Yuyuan, Liu Pengfei

机构信息

Department of Neurosurgery, Binzhou Medical University Hospital, Binzhou, Shandong, China.

出版信息

J Craniofac Surg. 2024 Dec 9. doi: 10.1097/SCS.0000000000010988.

DOI:10.1097/SCS.0000000000010988
PMID:39656175
Abstract

BACKGROUND

Pituitary adenomas are common benign intracranial tumors. This study aimed to explore the relevant factors influencing the cavernous sinus medial wall invasion by Pituitary adenomas based on intraoperative evaluation. Meanwhile, the authors introduced a safe technique for the resection of the medial wall of the cavernous sinus and conducted a preliminary evaluation of the efficacy of this technique.

METHODS

The clinical data of 108 patients with pituitary adenomas who underwent surgery at our institution were collected. Binary logistic regression analysis was utilized to identify independent predictors of medial wall invasion. Furthermore, the authors performed medial wall resection on 12 cases of somatotroph adenomas with medial wall invasion to initially assess the surgical efficacy of this technique for somatotroph adenomas.

RESULTS

Multivariate Logistic regression analysis showed that tumor Knosp grade and somatotroph adenomas were independent predictors of medial wall invasion (P<0.05). For somatotroph adenomas, medial wall resection resulted in a high biochemical remission rate (83%), and all patients were free of recurrence at the last follow-up.

CONCLUSION

Higher knosp grade and somatotroph adenomas will increase the risk of medial wall invasion of the cavernous sinus. Relying solely on the Knosp grade system to evaluate tumor invasion of the medial wall without differentiating between tumor subtypes is inaccurate. Invasion of the medial wall may be a cause of low biochemical remission rates and recurrence after surgery for somatotroph adenomas. The technique of medial wall resection is safe and effective, and holds significant importance in the treatment of somatotroph adenomas.

摘要

背景

垂体腺瘤是常见的颅内良性肿瘤。本研究旨在基于术中评估探讨影响垂体腺瘤海绵窦内侧壁侵犯的相关因素。同时,作者介绍一种切除海绵窦内侧壁的安全技术,并对该技术的疗效进行初步评估。

方法

收集在本机构接受手术的108例垂体腺瘤患者的临床资料。采用二元逻辑回归分析确定内侧壁侵犯的独立预测因素。此外,作者对12例伴有内侧壁侵犯的生长激素腺瘤患者进行内侧壁切除术,初步评估该技术对生长激素腺瘤的手术疗效。

结果

多因素逻辑回归分析显示,肿瘤Knosp分级和生长激素腺瘤是内侧壁侵犯的独立预测因素(P<0.05)。对于生长激素腺瘤,内侧壁切除术后生化缓解率较高(83%),所有患者在末次随访时均无复发。

结论

较高的Knosp分级和生长激素腺瘤会增加海绵窦内侧壁侵犯的风险。单纯依靠Knosp分级系统评估肿瘤对内侧壁的侵犯而不区分肿瘤亚型是不准确的。内侧壁侵犯可能是生长激素腺瘤术后生化缓解率低和复发的原因之一。内侧壁切除术安全有效,在生长激素腺瘤的治疗中具有重要意义。

相似文献

1
Invasion of the Cavernous Sinus Medial Wall by Pituitary Adenomas: Intraoperative Evaluation and the Clinical Efficacy of the Cavernous Sinus Medial Wall Resection in the Treatment of Somatotroph Adenomas.垂体腺瘤侵犯海绵窦内侧壁:术中评估及海绵窦内侧壁切除术治疗生长激素腺瘤的临床疗效
J Craniofac Surg. 2024 Dec 9. doi: 10.1097/SCS.0000000000010988.
2
Extended Resection of Cavernous Sinus Medial Wall Improves Remission Rates in Somatotroph Pituitary Neuroendocrine Tumors: A Strategy to Inspect Anatomical Interface.海绵窦内侧壁扩大切除术可提高生长激素型垂体神经内分泌肿瘤的缓解率:一种检查解剖界面的策略
World Neurosurg. 2025 May;197:123883. doi: 10.1016/j.wneu.2025.123883. Epub 2025 Mar 8.
3
Efficacy of transsphenoidal surgery in achieving biochemical cure of growth hormone-secreting pituitary adenomas among patients with cavernous sinus invasion: a systematic review and meta-analysis.经蝶窦手术对海绵窦侵袭性生长激素分泌型垂体腺瘤患者实现生化治愈的疗效:一项系统评价和荟萃分析
Neurol Res. 2017 May;39(5):387-398. doi: 10.1080/01616412.2017.1296653. Epub 2017 Mar 16.
4
Efficacy and safety of cavernous sinus medial wall resection in pituitary adenoma surgery: a systematic review and a single-arm meta-analysis.经海绵窦内侧壁切除术治疗垂体腺瘤手术的疗效和安全性:系统评价和单臂荟萃分析。
Pituitary. 2023 Aug;26(4):340-351. doi: 10.1007/s11102-023-01332-5. Epub 2023 Jun 29.
5
Silent Corticotroph Adenomas Demonstrate Predilection for Sphenoid Sinus, Cavernous Sinus, and Clival Invasion Compared with Other Subtypes.与其他亚型相比,沉默型促肾上腺皮质激素腺瘤更倾向于侵犯蝶窦、海绵窦和斜坡。
World Neurosurg. 2024 Nov;191:e41-e47. doi: 10.1016/j.wneu.2024.08.027. Epub 2024 Aug 21.
6
Preoperative predictors of biochemical remission in somatotroph adenoma resections: a single-institution retrospective review.生长激素腺瘤切除术生化缓解的术前预测因素:单机构回顾性研究
J Neurosurg. 2024 Nov 15;142(3):756-765. doi: 10.3171/2024.7.JNS24373. Print 2025 Mar 1.
7
Cavernous Sinus Invasion in Pituitary Adenomas: Systematic Review and Pooled Data Meta-Analysis of Radiologic Criteria and Comparison of Endoscopic and Microscopic Surgery.垂体腺瘤的海绵窦侵犯:放射学标准的系统评价与汇总数据荟萃分析以及内镜手术与显微镜手术的比较
World Neurosurg. 2016 Dec;96:36-46. doi: 10.1016/j.wneu.2016.08.088. Epub 2016 Aug 30.
8
Aggressive transsphenoidal resection of tumors invading the cavernous sinus in patients with acromegaly: predictive factors, strategies, and outcomes.肢端肥大症患者侵袭海绵窦肿瘤的积极经蝶窦切除术:预测因素、策略及结果
J Neurosurg. 2014 Sep;121(3):505-10. doi: 10.3171/2014.3.JNS132214. Epub 2014 Jul 11.
9
Prospective intraoperative and histologic evaluation of cavernous sinus medial wall invasion by pituitary adenomas and its implications for acromegaly remission outcomes.前瞻性评估垂体腺瘤对海绵窦内侧壁的术中及组织学侵犯及其对肢端肥大症缓解结果的影响。
Sci Rep. 2022 Jun 15;12(1):9919. doi: 10.1038/s41598-022-12980-1.
10
Comparative analysis of growth hormone-secreting mixed gangliocytomas and pure growth hormone pituitary adenomas.分泌生长激素的混合性神经节细胞瘤与纯生长激素垂体腺瘤的对比分析
Clin Neurol Neurosurg. 2025 Oct;257:109097. doi: 10.1016/j.clineuro.2025.109097. Epub 2025 Aug 5.

引用本文的文献

1
Research progress on quercetin in improving the survival rate of random skin flap.槲皮素提高随意皮瓣成活率的研究进展
Arch Dermatol Res. 2025 Jan 16;317(1):267. doi: 10.1007/s00403-024-03696-5.